case_images: PMC10518174_01
case_images: Clinical progress of atopic dermatitis.
case_images: CCID-16-2561-g0004.jpg
case_images: PMC10518174_01_CCID-16-2561-g0004.jpg
case_images: f0003
case_images: Erythema, papules, edema, exudation, dryness, scale, and lichenification were observed in the distal area below both limb joints (Objective SCORAD 49.9; Figures 3 and 4). The patient's symptoms were severe in the distal joints of the fingers, accompanied by scratches and bleeding around the affected areas due to itching and scratching (Subjective SCORAD 13; Figures 3 and 4). Overall skin symptoms improved from 49.9 to 23.8 on the objective SCORAD index, except for light scratches and pigmentation (Figures 3 and 4).
case_images: Progress score of the Scoring Atopic Dermatitis and the Dermatology Life Quality Index.
case_images: CCID-16-2561-g0005.jpg
case_images: PMC10518174_01_CCID-16-2561-g0005.jpg
case_images: f0004
case_images: Erythema, papules, edema, exudation, dryness, scale, and lichenification were observed in the distal area below both limb joints (Objective SCORAD 49.9; Figures 3 and 4). The patient's symptoms were severe in the distal joints of the fingers, accompanied by scratches and bleeding around the affected areas due to itching and scratching (Subjective SCORAD 13; Figures 3 and 4). The affected areas were sore and painful (DLQI 19; Figure 4). Overall skin symptoms improved from 49.9 to 23.8 on the objective SCORAD index, except for light scratches and pigmentation (Figures 3 and 4). The subjective SCORAD index improved from 13 to 5, which was less than half of the first diagnosis, and the patient's quality of life improved significantly from a DLQI score of 19 to 7 (Figure 4). The total SCORAD index score improved to 23.5, and the DLQI score also improved to 5 (Figure 4).
case_images: Progress of the accompanying systemic symptoms.
case_images: CCID-16-2561-g0006.jpg
case_images: PMC10518174_01_CCID-16-2561-g0006.jpg
case_images: f0005
case_images: The patient's ASS also improved from an NRS score of 25 to 8, compared to the first visit (Figure 5). 